NT-pro-BNP is associated with long-term outcome in a heterogeneous sample of cardiac inpatients

European Journal of Internal Medicine

Volumn 18, Issue 3, 2007, Pages 215-220

  Pfister, Roman ^a   Tan, Dajana ^a   Thekkanal, Jaimy ^a   Hellmich, Martin ^a   Schneider, Christian Alfons ^a  

^a UNIVERSITY OF COLOGNE   (Germany)

Author keywords

Cardiovascular disease; Heart failure; Natriuretic peptides; NT pro BNP; Prognosis

Indexed keywords

BRAIN NATRIURETIC PEPTIDE;

ACUTE HEART FAILURE; AGED; AREA UNDER THE CURVE; ARTICLE; CARDIOVASCULAR RISK; CEREBROVASCULAR ACCIDENT; CONTROLLED STUDY; CORONARY VESSEL MALFORMATION; DIABETES MELLITUS; FEMALE; HOSPITAL DISCHARGE; HOSPITALIZATION; HUMAN; KIDNEY FUNCTION; LONG TERM CARE; MAJOR CLINICAL STUDY; MALE; STROKE; SYSTOLIC DYSFUNCTION; TRANSLUMINAL CORONARY ANGIOPLASTY; UNIVERSITY HOSPITAL;

EID: 34247173394     PISSN: 09536205     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejim.2006.11.007     Document Type: Article

References (26)

1. Sans S., Kesteloot H., and Kromhout D. The burden of cardiovascular diseases mortality in Europe. Task Force of the European Society of Cardiology on Cardiovascular Mortality and Morbidity Statistics in Europe. Eur Heart J 18 (1997) 1231-1248
2. Haldeman G.A., Croft J.B., Giles W.H., and Rashidee A. Hospitalization of patients with heart failure: National Hospital Discharge Survey, 1985 to 1995. Am Heart J 137 (1999) 352-360
3. Blomkalns A.L., and Gibler W.B. Markers and the initial triage and treatment of patients with chest pain. Cardiovasc Toxicol 1 (2001) 111-115
4. Stewart S., Pearson S., and Horowitz J.D. Effects of a home-based intervention among patients with congestive heart failure discharged from acute hospital care. Arch Intern Med 158 (1998) 1067-1072
5. Maeda K., Tsutamoto T., Wada A., Hisanaga T., and Kinoshita M. Plasma brain natriuretic peptide as a biochemical marker of high left ventricular end-diastolic pressure in patients with symptomatic left ventricular dysfunction. Am Heart J 135 (1998) 825-832
6. Pfister R., Scholz M., Wielckens K., Erdmann E., and Schneider C.A. Use of NT-proBNP in routine testing and comparison to BNP. Eur J Heart Fail 6 (2004) 289-293
7. Gardner R.S., Ozalp F., Murday A.J., Robb S.D., and McDonagh T.A. N-terminal pro-brain natriuretic peptide. A new gold standard in predicting mortality in patients with advanced heart failure. Eur Heart J 24 (2003) 1735-1743
8. James S.K., Lindahl B., Siegbahn A., Stridsberg M., Venge P., Armstrong P., et al. N-terminal pro-brain natriuretic peptide and other risk markers for the separate prediction of mortality and subsequent myocardial infarction in patients with unstable coronary artery disease: a Global Utilization of Strategies To Open occluded arteries (GUSTO)-IV substudy. Circulation 108 (2003) 275-281
9. Kragelund C., Gronning B., Kober L., Hildebrandt P., and Steffensen R. N-terminal pro-B-type natriuretic peptide and long-term mortality in stable coronary heart disease. N Engl J Med 352 (2005) 666-675
10. Cockcroft D.W., and Gault M.H. Prediction of creatinine clearance from serum creatinine. Nephron 16 (1976) 31-41
11. Schneider C.A., Helmig A.K., Baer F.M., Horst M., Erdmann E., and Sechtem U. Significance of exercise-induced ST-segment elevation and T-wave pseudonormalization for improvement of function in healed Q-wave myocardial infarction. Am J Cardiol 82 (1998) 148-153
12. Kannel W.B., D'Agostino R.B., Silbershatz H., Belanger A.J., Wilson P.W., and Levy D. Profile for estimating risk of heart failure. Arch Intern Med 159 (1999) 1197-1204
13. Richards A.M., Nicholls M.G., Yandle T.G., Frampton C., Espiner E.A., Turner J.G., et al. Plasma N-terminal pro-brain natriuretic peptide and adrenomedullin: new neurohormonal predictors of left ventricular function and prognosis after myocardial infarction. Circulation 97 (1998) 1921-1929
14. Bettencourt P., Azevedo A., Pimenta J., Frioes F., Ferreira S., and Ferreira A. N-terminal-pro-brain natriuretic peptide predicts outcome after hospital discharge in heart failure patients. Circulation 110 (2004) 2168-2174
15. Wang T.J., Larson M.G., Levy D., Benjamin E.J., Leip E.P., Omland T., et al. Plasma natriuretic peptide levels and the risk of cardiovascular events and death. N Engl J Med 350 (2004) 655-663
16. de Lemos J.A., Morrow D.A., Bentley J.H., Omland T., Sabatine M.S., McCabe C.H., et al. The prognostic value of B-type natriuretic peptide in patients with acute coronary syndromes. N Engl J Med 345 (2001) 1014-1021
17. De S.J., De B.D., Cuypers S., Delanghe J., De B.M., Kornitzer M., et al. Plasma N-terminal pro-brain natriuretic peptide concentration predicts coronary events in men at work: a report from the BELSTRESS study. Eur Heart J 26 (2005) 2644-2649
18. Richards A.M., Nicholls M.G., Espiner E.A., Lainchbury J.G., Troughton R.W., Elliott J., et al. B-type natriuretic peptides and ejection fraction for prognosis after myocardial infarction. Circulation 107 (2003) 2786-2792
19. Kistorp C., Raymond I., Pedersen F., Gustafsson F., Faber J., and Hildebrandt P. N-terminal pro-brain natriuretic peptide, C-reactive protein, and urinary albumin levels as predictors of mortality and cardiovascular events in older adults. JAMA 293 (2005) 1609-1616
20. Olsen M.H., Wachtell K., Tuxen C., Fossum E., Bang L.E., Hall C., et al. N-terminal pro-brain natriuretic peptide predicts cardiovascular events in patients with hypertension and left ventricular hypertrophy: a LIFE study. J Hypertens 22 (2004) 1597-1604
21. Luchner A., Hengstenberg C., Lowel H., Trawinski J., Baumann M., Riegger G.A., et al. N-terminal pro-brain natriuretic peptide after myocardial infarction: a marker of cardio-renal function. Hypertension 39 (2002) 99-104
22. Engelmann M.D., Niemann L., Kanstrup I.L., Skagen K., and Godtfredsen J. Natriuretic peptide response to dynamic exercise in patients with atrial fibrillation. Int J Cardiol 105 (2005) 31-39
23. Bibbins-Domingo K., Ansari M., Schiller N.B., Massie B., and Whooley M.A. B-type natriuretic peptide and ischemia in patients with stable coronary disease: data from the Heart and Soul study. Circulation 108 (2003) 2987-2992
24. Luchner A., Hengstenberg C., Lowel H., Riegger G.A., Schunkert H., and Holmer S. Effect of compensated renal dysfunction on approved heart failure markers. Direct comparison of Brain Natriuretic Peptide (BNP) and N-terminal pro-BNP. Hypertension (2005)
25. Mann J.F., Gerstein H.C., Pogue J., Bosch J., and Yusuf S. Renal insufficiency as a predictor of cardiovascular outcomes and the impact of ramipril: the HOPE randomized trial. Ann Intern Med 134 (2001) 629-636
26. Adams Jr. K.F., Fonarow G.C., Emerman C.L., LeJemtel T.H., Costanzo M.R., Abraham W.T., et al. Characteristics and outcomes of patients hospitalized for heart failure in the United States: rationale, design, and preliminary observations from the first 100,000 cases in the Acute Decompensated Heart Failure National Registry (ADHERE). Am Heart J 149 (2005) 209-216